Depression is a debilitating and prevalent condition affecting more than 340 million people worldwide. Long-term exposure to mild stressors is the main cause of depression. Therefore, chronic unpredictable mild stress (CUMS) is a reliable and effective model in inducing anxiety and depressive-like behaviors in animals [19]. In this model, anhedonia, which is the most important symptom of depression, is assessed by the sucrose preference test. The open field test investigated animal exploratory behavior, and the elevated plus maze assessed anxiety [19, 20].
In the present study, CUMS was used to induce depression, and results indicate the induction of depressive-like behaviors, impaired cognitive function, and biochemical and structural changes of the hippocampus in animals.
The hippocampus is a part of the medial temporal lobe, which is involved in many behavioral and cognitive functions, and is highly susceptible to face the damaging effects of stress [21]. Exposure to stress is associated with excessive release of corticosteroids followed by hyperactivity of the HPA axis [22]. For almost 80 years, there has been much focus on glucocorticoids, released during the activation of the HPA axis, and acted as the primary mediators of the effects of stress on the hippocampus [7, 23]. The hippocampus has a high density of corticosteroid receptors, especially glucocorticoid receptors which are the main reasons for the sensitivity of the hippocampus toward stress [24]. In the current study, a significant increase in serum corticosterone levels in rats exposed to chronic stress was observed, indicating increased HPA axis activity. Among the systems involved in stress is the immune system. Stimulation of the immune system leads to the increased production of pro-inflammatory cytokines, which in the long-term results in dysregulation of the neuroendocrine system [25]. Another conventional hypothesis about the cause of depression is the hypothesis of monoamines, especially serotonin and norepinephrine, which are the main targets of many pharmacological interventions [26, 27]. Thus, various factors are involved in the etiology and harmful effects of depression, such as hyperactivity of the HPA axis, deficiency of monoamines, neuroinflammation, and brain-derived neurotrophic factor changes [6, 7, 25, 27]. There is also growing evidence showing a relationship between depression and oxidative stress [28]. The increase of free radicals and disruption of oxidant balance during stress provide a basis for oxidative damage to the nervous system. The brain is vulnerable to oxidative insults due to its high energy requirement, abundance of lipids, and weak antioxidant system [28, 29].
The results of this study also indicate an increase in malondialdehyde in the hippocampus of depressed animals. MDA level is a lipid peroxidation index and the cause of oxidative stress. However, there was no change in the activity of antioxidant enzymes. According to the results of our previous study, it can be justified that the activity of antioxidants increases during stress due to the increase in oxidative stress. Nevertheless, an extended period of stress may ultimately lead to a decrease in the expression of antioxidant enzymes, resulting in no significant change in antioxidant activity [30].
Despite pharmacological interventions and numerous psychotherapies, most people with depression do not fully recover. The insufficient response to treatment underscores the necessity for an improved understanding of the underlying causes and the development of more suitable treatment approaches. Considering the importance of oxidative stress and inflammatory factors in the emergence and development of depression, they can be a suitable therapeutic target for depression [31].
In this study, methane-rich saline (MRS) was used to reduce the effects of CUMS. Methane is the simplest alkane and the most abundant organic gas in the atmosphere and is commonly used as a fuel. Endogenous methane is mainly produced by methanogenic microorganisms in the large intestine during transient oxygen deprivation and also in the liver mitochondria during anaerobic respiration. Due to its limited solubility in water, methane easily permeates through membranes [32]. The mitochondria represent one of the primary target organelles affected by methane. Mitochondria are involved in energy production, calcium homeostasis, intrinsic apoptosis, and the formation of oxygen free radicals [32]. Studies have shown that methane can affect all mitochondrial functions. Interestingly, exogenous methane has been shown to limit oxidative stress pathways by improving basal respiration and modulating mitochondrial oxidative phosphorylation, which directs oxygen consumption towards energy production and reduces the production of oxygen free radicals [33]. In recent years, methane has had promising protective effects on various models of ischemia and inflammation. In the first study conducted in 2012, the anti-inflammatory effect of inhaled methane was proven in the intestinal ischemia model [34], followed by further research on the protective effect of methane in various models of ischemia of the myocardium, brain, spinal cord, lung, and intestinal and liver inflammation, and diabetic retinopathy [35]. For the first time, Yu et al. (2015) used methane-rich saline to reduce liver ischemia-reperfusion injury [36], which was also applied in subsequent studies. Most of these studies have focused on methane's antioxidant, anti-inflammatory, and anti-apoptotic properties [37, 38].
In the present study, the effect of methane-rich saline on CUMS was studied. The results of the study of depressive-like behaviors indicate an increase in the sucrose preference, which is a sign of reducing anhedonia and immobility and improving exploratory behaviors and cognitive functions in depressed animals treated with methane. Also, methane decreased hippocampal lipid peroxidation and serum corticosterone levels. The decrease in hippocampal lipid peroxidation and serum corticosterone levels suggests methane's potential antioxidant and anti-inflammatory effects. This damage reduction and improved hippocampal functions following CUMS can be attributed to methane's beneficial properties.
The protective effects of methane have been shown in various neurological disorders. The neuroprotective effects of MRS have been investigated in the model of acute poisoning with carbon monoxide. Methane has been able to protect the brain against the damage caused by carbon monoxide by reducing inflammatory cytokines and improving antioxidant enzymes [39]. In the brain trauma model, methane, by blocking the pathway of the Wnt, reduced the inflammatory and oxidative responses and inhibited apoptosis, and finally improved the cognitive function of animals [40]. In another study, methane inhalation reduced neurological dysfunction following cerebral ischemia-reperfusion by activating the PI3K/Akt/HO-1-dependent antioxidant pathway [41]. In two other studies, the effect of methane on spinal cord ischemia-reperfusion was investigated. In one of them, methane was able to reduce the damage caused by oxidative and inflammatory factors released during ischemia by reducing the activity of microglia in neurons [42]. In another study, by activating Nrf2, methane caused the upregulation of antioxidant enzymes, inhibition of free radicals, and reduction of apoptotic factors caspase 3 and Bax [43]. In a model of inflammation caused by LPS, methane was able to inhibit the NF-κB/MAPK inflammatory pathway and increase the release of the anti-inflammatory cytokine IL-10, proving methane's strong anti-inflammatory effect [44].